المؤلفون: Huamao M. Lin, Myung-Ju Ahn, Pingkuan Zhang, Angelo Delmonte, Marcello Tiseo, D. Ross Camidge, Frank Griesinger, Scott N. Gettinger, Dong Wan Kim, Maria Rosario Garcia Campelo, Maximilian Hochmair, Enriqueta Felip, Ki Hyeong Lee, Alexander I. Spira, Q. Ni, Neeraj Gupta, Michael J. Hanley, James Chih-Hsin Yang, Hye Ryun Kim, Sanjay Popat, Ji Youn Han, Raffaele Califano

المساهمون: Institut Català de la Salut, [Camidge DR] University of Colorado Cancer Center, Aurora, CO. [Kim HR] Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. [Ahn MJ] Samsung Medical Center, Seoul, South Korea. [Yang JCH] National Taiwan University Hospital, Taipei, Taiwan. [Han JY] National Cancer Center, Goyang, South Korea. [Hochmair MJ] Department of Respiratory and Critical Care Medicine, Krankenhaus Nord–Klinik Floridsdorf, Vienna, Austria. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Journal of Clinical Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Other subheadings::Other subheadings::/drug therapy [Other subheadings], ALECTINIB, 0302 clinical medicine, QUALITY-OF-LIFE, Carcinoma, Non-Small-Cell Lung, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, OUTCOMES, QLQ-C30, ORIGINAL REPORTS, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], CHEMOTHERAPY, Middle Aged, Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Progression-Free Survival, Survival Rate, SAFETY, 030220 oncology & carcinogenesis, Female, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Brigatinib, diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug_class, EGFR, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antineoplastic Agents, Young Adult, 03 medical and health sciences, Organophosphorus Compounds, Crizotinib, Internal medicine, medicine, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Progression-free survival, Thoracic Oncology, Lung cancer, Survival rate, Aged, Medicaments antineoplàstics - Ús terapèutic - Eficàcia, Science & Technology, business.industry, Receptor Protein-Tyrosine Kinases, 1103 Clinical Sciences, KINASE INHIBITOR, neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], EFFICACY, medicine.disease, Interim analysis, ALK inhibitor, EML4-ALK FUSION GENE, Pyrimidines, 030104 developmental biology, Quality of Life, business, Pulmons - Càncer - Tractament

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc7081ad44ad8535823a537fe2ae82eTest
https://doi.org/10.1200/jco.20.00505Test

المؤلفون: Chloe E. Atreya, Tae Won Kim, Elena Elez, Ravit Geva, Hiroki Hara, Tong Dai, Hiroya Taniguchi, Luis A. Diaz, Dung T. Le, Patrick McKay Boland, Rosine Guimbaud, Salah-Eddin Al-Batran, Todd S. Crocenzi, Matthew Burge, Thierry André, Petr Kavan, Dirk Jäger, Eric Van Cutsem, Yi Cui, Takayuki Yoshino, Patricia Marinello, Bert H. O'Neil

المساهمون: Institut Català de la Salut, [Le DT] Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. [Kim TW] Asan Medical Center, Seoul, Republic of Korea. [Van Cutsem E] University Hospitals Gasthuisberg Leuven, KU Leuven, Leuven, Belgium. [Geva R] Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. [Jäger D] Nationales Centrum Tumorerkrankungen, Heidelberg, Germany. [Hara H] Saitama Cancer Center, Saitama, Japan. [Elez E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Journal of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 1
Scientia

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Colorectal cancer, Medicaments antineoplàstics - Ús terapèutic, Pembrolizumab, Other subheadings::Other subheadings::/drug therapy [Other subheadings], DNA Mismatch Repair, Cohort Studies, 0302 clinical medicine, Open label study, Còlon - Càncer, Neoplasms, Monoclonal, Gastrointestinal Cancer, 80 and over, Humanized, Antitumor activity, Treatment refractory, Neoplasms::Neoplastic Processes::Neoplasm Metastasis [DISEASES], Middle Aged, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES], Treatment Outcome, Immunological, Oncology, 030220 oncology & carcinogenesis, Recte - Càncer, Female, DNA mismatch repair, Microsatellite Instability, Colorectal Neoplasms, Intravenous, Adult, Infusions, Clinical Sciences, Oncology and Carcinogenesis, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antineoplastic Agents, and over, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Antibodies, Young Adult, 03 medical and health sciences, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES], RAPID COMMUNICATIONS, medicine, Humans, Oncology & Carcinogenesis, Aged, business.industry, Microsatellite instability, medicine.disease, 030104 developmental biology, neoplasias::procesos neoplásicos::metástasis neoplásica [ENFERMEDADES], Cancer research, business, Biomarkers

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e32a08c4df7c6cb8ee9117861ced13eTest
http://europepmc.org/articles/PMC7031958Test

المؤلفون: Adriana Papadimitropoulou, Ruth Lupu, Sara Verdura, Bharvi P Oza-Gajera, Travis Vander Steen, Elisabet Cuyàs, Luciano Vellon, Javier A. Menendez, Ingrid Espinoza, Inderjit Mehmi

المصدر: Cancers, Vol 13, Iss 1132, p 1132 (2021)
Cancers, 2021, vol. 13, num. 5, p. 1132
Articles publicats (IdIBGi)
Menéndez Menéndez, Javier Abel Papadimitropoulou, Adriana Steen, Travis Vander Cuyàs, Elisabet Oza-Gajera, Bharvi P. Verdura, Sara Espinoza, Ingrid Vellon, Luciano Mehmi, Inderjit Lupu, Ruth 2021 Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer Cancers 13 5 1132
DUGiDocs – Universitat de Girona
instname
Cancers
Volume 13
Issue 5

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.drug_class, Estrogen receptor, Mama -- Càncer -- Tractament, lcsh:RC254-282, Article, Medicaments antineoplàstics, endocrine resistance, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Growth factor receptor, Estrògens -- Receptors, Estrogen -- Receptors, Tamoxifèn, HER2, Antineoplastic agents, medicine, skin and connective tissue diseases, Protein kinase B, fatty acid synthase, Breast -- Cancer -- Treatment, tamoxifen, biology, Chemistry, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Tamoxifen, Fatty acid synthase, 030104 developmental biology, Oncology, Estrogen, 030220 oncology & carcinogenesis, Breast -- Cancer -- Endocrine aspects, Cancer research, biology.protein, Mama -- Càncer -- Aspectes endocrins, estrogen receptor, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bebf34852adf439730250ad45b4c7c6fTest
https://pubmed.ncbi.nlm.nih.gov/33800852Test

المؤلفون: Chloe Baker, Emma Hall, Daniel Nava Rodrigues, Claudia Bertan, Susana Miranda, Nuria Porta, Ruth Riisnaes, Mateus Crespo, Alec Paschalis, Wei Yuan, Joaquin Mateo, Johann S. de Bono, Sara Arce-Gallego, Stephen J. Pettitt, Violeta Serra, Bora Gurel, Suzanne Carreira, Diletta Bianchini, Jane Goodall, Pasquale Rescigno, Christopher J. Lord, Alba Llop-Guevara, Ana Ferreira, Rita Pereira, Jan Rekowski, George Seed, Ines Figueiredo

المساهمون: Institut Català de la Salut, [Carreira S, Porta N, Seed G] The Institute of Cancer Research, London, UK. [Arce-Gallego S, Llop-Guevara A, Serra V] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mateo J] The Institute of Cancer Research, London, UK. The Royal Marsden NHS Foundation Trust, London, UK. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Cancer Discovery
Scientia

مصطلحات موضوعية: 0301 basic medicine, Male, ADN - Reparació, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms [DISEASES], Genetic Phenomena::DNA Repair [PHENOMENA AND PROCESSES], DNA Repair, DNA repair, PALB2, RAD51, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors, Other subheadings::Other subheadings::/drug therapy [Other subheadings], fenómenos genéticos::reparación del ADN [FENÓMENOS Y PROCESOS], Germline, Medicaments antineoplàstics, Olaparib, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Humans, business.industry, Prostatic Neoplasms, Pròstata - Càncer - Tractament, medicine.disease, 3. Good health, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata [ENFERMEDADES], 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, PARP inhibitor, Cancer research, Homologous recombination, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5d78c938c629cb6907d0513760b356Test
https://pubmed.ncbi.nlm.nih.gov/34045297Test

المؤلفون: Laura Herrero, Marta López, Nicolás Montesdeoca, Xavier Ariza, Kamil Makowski

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: 0301 basic medicine, Cell division, Antineoplastic Agents, Biology, Biochemistry, Medicaments antineoplàstics, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Neoplasms, Nitriles, Antineoplastic agents, Genetics, Lipogenic enzymes, medicine, Humans, Dicarboxylic Acids, Enzyme Inhibitors, Molecular Biology, Fatty acid synthesis, chemistry.chemical_classification, Lipogenesis, Fatty Acids, Cancer, Lipid metabolism, Lipid Metabolism, medicine.disease, Metabolisme dels lípids, Enzymes, Metabolic pathway, 030104 developmental biology, Enzyme, chemistry, Cancer cell, Cancer research, Azetidines, Pyrazoles, Fatty Acid Synthases, Enzims, 030217 neurology & neurosurgery, Biotechnology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f25d2436c772b66cc57fbf507c375bTest
https://doi.org/10.1021/scimeetings.3c00627Test

المؤلفون: Elvira Buxó, Raquel Hernández, Marcelo Garrido, Mónica Granja, Alicia Hurtado, Olbia Serra, Rosario Vidal Tocino, Ismael Macias, Almudena Cotes Sanchís, Virginia Arrazubi, Ana Custodio, Juana María Cano, Javier Gallego, Avinash Ramchandani, Ana Montes, Paula Jiménez-Fonseca, Juan Diego Cacho, Marta Martín Richard, P. Reguera, Carlos F. Lopez, Alberto Carmona-Bayonas, Laura Visa, Carolina Hernández Pérez, Nieves Martinez Lago, Gema Aguado, María Luisa Limón, Alfonso Martín Carnicero, Paola Pimentel, Flora López, Aitor Azkarate

المصدر: PLoS ONE, Vol 15, Iss 7, p e0235848 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
PLoS ONE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

مصطلحات موضوعية: 0301 basic medicine, Male, sistema de registros, humanos, Cancer Treatment, Platinum Compounds, Gastroenterology, Metastasis, Medicaments antineoplàstics, 0302 clinical medicine, Antineoplastic Agents, Immunological, Quality of life, Trastuzumab, Basic Cancer Research, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Medicine, Registries, antineoplásicos, mediana edad, neoplasias gástricas, Aged, 80 and over, anciano, Multidisciplinary, protocolos de quimioterapia antineoplásica combinada, Advanced gastric cancer, Middle Aged, adulto, análisis de supervivencia, Chemistry, Oncology, Qualitat de vida, 030220 oncology & carcinogenesis, Physical Sciences, Population study, Female, compuestos de platino, medicine.drug, Research Article, Chemical Elements, Adult, medicine.medical_specialty, Stomach cancer, Science, Estómac-- Malalties, Antineoplastic Agents, Ramucirumab, 03 medical and health sciences, Metàstasi, Stomach Neoplasms, Internal medicine, Gastrointestinal Tumors, Humans, Survival analysis, Platinum, Aged, Second line treatment, Aparell digestiu--Càncer--Registres, business.industry, Càncer d'estómac, Cancers and Neoplasms, medicine.disease, Antineoplastic Agents, Phytogenic, Survival Analysis, Drug Utilization, Health Care, Gastric Cancer, 030104 developmental biology, Metastatic Tumors, Quality of Life, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3ced905477a64fe5f76bc6895f20ebTest
https://hdl.handle.net/20.500.13003/11571Test

المؤلفون: Noelia Martínez, Paolo Nuciforo, Begoña Bermejo, Laia Paré, Patricia Villagrasa, Serafin Morales, J. Alarcón, Eva Ciruelos, Olga Martínez, Tomás Pascual, Aleix Prat, Montserrat Muñoz, Barbara Adamo, I Garau, Sara Gregorio, Fara Brasó-Maristany, Gaia Griguolo, Javier Cortes, Roger R. Gomis, Nuria Chic, Rafael López, Sonia Pernas, Maria Vidal, Antonio Llombart-Cussac, Mafalda Oliveira, Patricia Galván, Eduardo Martínez, Luis Manso

المساهمون: Institut Català de la Salut, [Brasó-Maristany F] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. [Griguolo G] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani, 2, 35124 Padova, Italy. Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Via Gattamelata, 64, 35128 Padova, Italy. [Pascual T] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. SOLTI Breast Cancer Research Group, Carrer de Balmes, 115, 08008 Barcelona, Spain. [Paré L] SOLTI Breast Cancer Research Group, Carrer de Balmes, 115, 08008 Barcelona, Spain. [Nuciforo P, Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Llombart-Cussac A] Hospital Universitario Arnau de Vilanova, Carrer de Sant Clement, 12, 46015 Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Nature Communications
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
NATURE COMMUNICATIONS
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)

مصطلحات موضوعية: 0301 basic medicine, Receptor, ErbB-2, Biopsy, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], humanos, resistencia a medicamentos, Drug Resistance, General Physics and Astronomy, Medicaments antineoplàstics - Ús terapèutic, neoplasias de la mama, Disease, Drug resistance, supervivencia celular, Antineoplastic Agents, Immunological, 0302 clinical medicine, Breast cancer, Mama - Càncer, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Medicine, antineoplásicos, Breast, Other subheadings::/therapeutic use [Other subheadings], Receptor, skin and connective tissue diseases, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Multidisciplinary, resultado del tratamiento, protocolos de quimioterapia antineoplásica combinada, línea celular, adulto, Phenotype, Neoadjuvant Therapy, Fenotip, Treatment Outcome, Oncology, mama, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Cell Survival, Science, biopsia, Antineoplastic Agents, Breast Neoplasms, Lapatinib, Article, General Biochemistry, Genetics and Molecular Biology, Cell Line, Càncer de mama, 03 medical and health sciences, Cell Line, Tumor, mental disorders, Biomarkers, Tumor, Humans, perfiles de expresión génica, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], neoplasms, tratamiento neoadyuvante, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], Gene Expression Profiling, General Chemistry, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Blockade, 030104 developmental biology, Drug Resistance, Neoplasm, Cancer research, Gene expression, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c3ed99d6d73c9674b22dd22eda471f4Test
http://hdl.handle.net/2445/173290Test

المؤلفون: Joaquim Bosch-Barrera, Jorge Joven, Verónica Ruiz-Torres, Elisabet Cuyàs, Vicente Micol, Sara Verdura, Javier A. Menendez

المصدر: Pharmaceuticals, Vol 14, Iss 559, p 559 (2021)
Pharmaceuticals, 2021, vol. 14, núm. 6, p. 559
Articles publicats (IdIBGi)
Verdura, Sara Cuyàs, Elisabet Ruiz-Torres, Verónica Micol, Vicente Joven, Jorge Bosch Barrera, Joaquim Menéndez Menéndez, Javier Abel 2021 Lung Cancer Management with Silibinin: A Historical and Translational Perspective Pharmaceuticals 14 6 559
DUGiDocs – Universitat de Girona
instname
Pharmaceuticals

مصطلحات موضوعية: 0301 basic medicine, silymarin, Pharmaceutical Science, Silibinin, Review, medicine.disease_cause, Metastasis, Medicaments antineoplàstics, Silybum marianum, STAT3, 03 medical and health sciences, chemistry.chemical_compound, Pharmacy and materia medica, 0302 clinical medicine, Metàstasi, Antineoplastic agents, Drug Discovery, medicine, Flavonolignan, metastasis, Lung cancer, non-small cell lung cancer, silibinin, biology, business.industry, EMT, medicine.disease, biology.organism_classification, Pulmons -- Càncer -- Tractament, RS1-441, Lungs -- Cancer -- Treatment, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Medicine, Molecular Medicine, KRAS, business, Brain metastasis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579fa63e1a756169d6701cc6a84fa132Test
https://doi.org/10.3390/ph14060559Test

المؤلفون: Javier A. Menendez, Marival Bermejo, Isabel González-Álvarez, Elisabet Cuyàs, Joaquim Bosch-Barrera, Verónica Ruiz-Torres, Sara Verdura, Almudena Pérez-Sánchez, Vicente Micol, Luz Agulló-Chazarra, Jorge Joven

المصدر: International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2019, vol.20, núm. 7, p.1606
Articles publicats (D-CM)
DUGiDocs – Universitat de Girona
instname
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1606 (2019)

مصطلحات موضوعية: 0301 basic medicine, Cell, Silibinin, Pharmacology, Blood–brain barrier, blood–brain barrier, Catalysis, Medicaments antineoplàstics, Inorganic Chemistry, lcsh:Chemistry, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic agents, Blood-Retinal Barrier, medicine, Flavonolignan, Humans, Milk Thistle, cancer, Physical and Theoretical Chemistry, Càncer, Molecular Biology, lcsh:QH301-705.5, Spectroscopy, Cancer, silibinin, Intestinal permeability, Plant Extracts, Communication, Organic Chemistry, General Medicine, medicine.disease, Computer Science Applications, Bioavailability, 030104 developmental biology, medicine.anatomical_structure, chemistry, lcsh:Biology (General), lcsh:QD1-999, Intestinal Absorption, Caco-2, 030220 oncology & carcinogenesis, Silybin, Caco-2 Cells, bioavailability

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe4f25e60aa3d77838b4171137dd96aTest
https://pubmed.ncbi.nlm.nih.gov/30935093Test

المؤلفون: Penalver, Francisco-Javier, Marquez, Jose-Antonio, Duran, Soledad, Giraldo, Pilar, Martin, Alejandro, Montalban, Carlos, Sancho, Juan-Manuel, Ramirez, Maria-Jose, Terol, Maria-Jose, Capote, Francisco-Javier, Gutierrez, Antonio, Sanchez, Blanca, Lopez, Andres, Salar, Antonio, Rodriguez-Caravaca, Gil, Canales, Miguel, Caballero, Maria-Dolores, Bello Lopez, Jose Luis, Carbonell, Felix, Ferrer Bordas, Secundino, Font Lopez, Patricia, Perez Persona, Ernesto, Lopez Guillermo, Armando, Hernandez Martin, Roberto, Ramon Mayans, Jose, Palomera, Luis, Perez Ceballos, Elena, Queizan Hernandez, Jose Antonio, Riaza Grau, Rosalia, de la Cruz, Fatima, Sanchez Salinas, Andres, GELTAMO Spanish Lymphoma Cooperati

المساهمون: [Peñalver FJ] Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain. [Márquez JA] Hospital de Basurto, Vizcaya, Spain. [Durán S] Complejo Hospitalario de Jaén, Jaén, Spain. [Giraldo P] Hospital Universitario Miguel Servet, Zaragoza, Spain. [Martín A] Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain. [Montalbán C] Hospital Universitario Ramón y Cajal, Madrid, Spain. [López A] Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Cancer medicine
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cancer Medicine. 2019;00:1–13.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Scientia
Cancer Medicine
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Cancer Medicine, Vol 8, Iss 16, Pp 6955-6966 (2019)

مصطلحات موضوعية: Male, 0301 basic medicine, Limfomes, Cancer Research, Lymphoma, dexametasona, humanos, resistencia a medicamentos, neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma folicular [ENFERMEDADES], Drug Resistance, Follicular lymphoma, Salvage therapy, Gastroenterology, Dexamethasone, Medicaments antineoplàstics, 0302 clinical medicine, Maintenance therapy, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, antineoplásicos, Lymphoma, Follicular, inmunoterapia, mediana edad, Original Research, anciano, protocolos de quimioterapia antineoplásica combinada, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Therapeutics::Therapeutics::Drug Therapy::Therapeutics::Drug Therapy::Drug Therapy, Combination::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Middle Aged, adulto, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, Oncology, 030220 oncology & carcinogenesis, Female, Rituximab, Immunotherapy, Refractory Follicular Lymphoma, medicine.drug, Adult, Bendamustine, medicine.medical_specialty, Prognosi, Antineoplastic Agents, Neutropenia, lcsh:RC254-282, 03 medical and health sciences, follicular lymphoma, Internal medicine, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, Follicular [DISEASES], medicine, Humans, Radiology, Nuclear Medicine and imaging, linfoma, bendamustine, Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Aged, Salvage Therapy, business.industry, Clinical Cancer Research, medicine.disease, tratamiento de última línea, immunochemotherapy, relapsed, refractory, mitoxantrona, 030104 developmental biology, Drug Resistance, Neoplasm, Neoplasm Recurrence, Local, Mitoxantrone, business, Febrile neutropenia, Diagnóstico::Pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b016266cc0c27999365889288230dbc8Test
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7284Test